(1)
Tuzi, A.; Lombardi, D.; Crivellari, D.; Militello, L.; Perin, T.; La Grassa, M.; Massarut, S.; Veronesi, A. Epirubicin and Docetaxel As Neoadjuvant Treatment of Hormone Receptor Positive, HER-2 Negative Breast Cancer: Results from Two Successive Phase II Studies. Radiol Oncol 2013, 47.